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The authors describe a biosensing concept based on the release of compounds, which are
encapsulated within lipid-coated porous silica microspheres, by detergents and toxins that disrupt
supported lipid bilayers SLBs on the microspheres. Suspension and microﬂuidic based methods
have been developed to monitor the release of the encapsulated compounds in response to
membrane disruption. The authors established that the SLBs on porous microspheres can endure
experimental conditions necessary for their incorporation into packed microchannels while
maintaining the bilayer integrity and functionality. Model compounds including a nonionic
detergent Triton X-100, a membrane active protein -hemolysin, and a membrane lytic
antimicrobial peptide melittin were successfully utilized to interact with different formulations of
SLBs on porous silica microspheres. The results demonstrate the stability of the SLBs on the
microspheres for several weeks, and the feasibility of using this system to detect the release of
ﬂuorescent dyes as well as other molecular reporters. The latter were detected by their involvement
in subsequent biospeciﬁc interactions that were detected by ﬂuorescence. This study exempliﬁes
proof of concept for developing new chemical and biochemical sensors and drug delivery systems
based on the disruption of lipid membranes coating porous silica microspheres that encapsulate dyes
or bioactive compounds. © 2008 American Institute of Physics. DOI: 10.1116/1.2918743
I. INTRODUCTION
Supported lipid bilayers SLBs on microspheres serve as
a biomimetic platform for several biotechnology applications
such as biosensing, molecular interactions, and drug
delivery.1–14 Microsphere SLBs combine the advantages of
maintaining a cell-like structure covered with lipid bilayers
that mimic cell membranes while eliminating problems asso-
ciated with using lipid vesicles.4,5,7,12,15 Thus, the lipid bi-
layer allows for incorporation of integral membrane proteins
and interactions with membrane active peptides while their
support on microspheres introduces long term stability, rig-
idness, deﬁned shapes and sizes, and ease of handling in
comparison to lipid vesicles.4,5,7,15,16 The lipid-coated micro-
spheres can be useful for a variety of high throughput screen-
ing methods.
SLBs typically have a thickness of 51 nm and were
ﬁrst stably formed on hydrophilic glass microspheres with a
water interface thicknesses of 1.2–2.2 nm between the SLB
and the microsphere surface.15 SLBs on microspheres retain
their ﬂuidity,7 which can be enhanced by modifying silica
microspheres with a hydrophilic polymer to form a cushion
for lipid bilayers.17 Furthermore, direct patterning of SLBs
on silica microspheres is achievable,18 which can allow the
presentation of biomolecules on microspheres in a controlled
manner in restricted areas.
Besides solid silica microspheres, porous silica micro-
spheres were used as supports for lipid bilayers.4,7,8,19 Mem-
brane proteins were successfully incorporated into SLBs on
porous silica microspheres4,7,8 while maintaining lateral mo-
bility within the SLB.7,8 Furthermore, recently, an artiﬁcial
system of cellular membrane proteins from a human colonic
adenocarcinoma cell line was reconstituted into SLB around
porous silica microspheres.19
Silica microspheres, solid or porous, coated with lipid bi-
layers were used in assays of biomolecular interac-
tions.1–4,6–11,13,14 These studies detected biomolecular inter-
actions by using various techniques, including measuring
zeta potential changes,9 evaluating dispersal of micro-
spheres,6,13 measuring ion conductance,8 or by employing
ﬂuorescence measurements, whether or not in suspension,
using a ﬂuorimeter, a ﬂow cytometer, or ﬂuorescence
aPresent address: Department of Mechanical Engineering, University of
Maryland, College Park, MD 20742.
bPresent address: College of Pharmacy, University of New Mexico, Albu-
querque, NM 87131.
cElectronic mail: gplopez@unm.edu
38 38Biointerphases 3„2…, June 2008 1934-8630/2008/3„2…/38/12/$23.00 ©2008 American Institute of Physics
microscopy,1–3,8,10,14 or by packing solid microspheres coated
with SLBs in microchannels with detection by using a
ﬂuorimeter.11
Microspheres with SLBs can be used in sensing schemes
that employ disruption of the SLB with agents that can dis-
rupt lipid bilayers or cell membranes. Detergents are an
example of such agents that solubilize lipid membranes
by forming detergent-lipid mixed micelles.20,21 Membrane
active proteins produced by microorganisms e.g.,
-hemolysin, streptolysin-O, and tetanus toxins,22–27 antimi-
crobial peptides produced by microorganisms against other
microbes e.g., alamethicin, magainin, and gramicidin,28–31
and components of venoms secreted by insects such as bees
melittin30,32 and black widow spiders -latrotoxin33 are a
few of the biomolecules that are known to disrupt lipid mem-
branes. Some membrane disrupting agents act by solubiliz-
ing the lipid bilayer, whereas others act through excessive
formation of pores or channels, which leads to the complete
disruption of the cell membranes or lipid bilayers. Such
agents have been used mainly with lipid vesicles; on the
other hand, we recently demonstrated the use of Triton
X-100 to disrupt SLBs on microspheres in a detection format
that employed a quencher and its superquenchable
polymer.14
Porous microspheres coated with SLBs offer an advantage
in biosensing applications and in drug delivery based on the
accessibility of the internal pore volume of these micro-
spheres from the surface. In fact, their pores were success-
fully loaded with ﬂuorescent dyes and encapsulated with
SLBs.7,8 SLBs on porous microspheres can be impermeable
to ions or molecules e.g., dyes and thus are capable of
forming enclosed compartments that separate the internal
and external chemical environments of the porous micro-
spheres, in much the same way as observed in cells. This
concept was conﬁrmed when SLBs were used as barriers to
external environment while encapsulating compounds,
within hydrogel microspheres, which were released upon
disruption of the lipid bilayer, thus allowing the interaction
of the hydrogels and their load with the external
environment.34 Although porous microspheres have been
used with SLBs to either incorporate functional membrane
proteins or encapsulate ﬂuorescent dyes stored within their
pores, the utility of releasing compounds stored within the
pores of the microspheres by disrupting the SLB has not
been exploited.
The goal of this study is to evaluate the use of porous
microspheres to release entrapped compounds by disrupting
the microsphere SLB using various membrane disrupting
agents. Our aims are to 1 characterize porous microspheres
loaded with a ﬂuorescent dye with SLB formed around them
and evaluate their stability, 2 establish the stability of the
SLB upon packing into a microchannel, 3 demonstrate the
utility of lipid-coated porous microspheres in sensing by de-
tecting the release of a ﬂuorescent dye upon disruption of
SLBs with membrane active agents in suspension assays and
in a microchannel format, and 4 utilize SLB disruption to
release nonﬂuorescent compounds that become involved in a
subsequent interaction, which is detectable by ﬂuorescence.
The fourth aim was carried out in a microchannel containing
two separated segments of microspheres. The ﬁrst one had
porous microspheres with SLBs to encapsulate biotin, and
the second one was made of microspheres coated with
streptavidin with bound ﬂuorescein-conjugated biotin. The
disruption of SLBs in the ﬁrst segment released biotin,
which, in turn, interacted with streptavidin in the second
downstream segment. The ﬂuorescence detection was based
on the dequenching of ostrich-quenched ﬂuorescein
biotin35,36 caused by the released biotin from the ﬁrst seg-
ment. The ostrich quenching of ﬂuorescein conjugated to bi-
otin results from the interaction of ﬂuorescein with a cis
binding pocket on streptavidin.35 The addition of biotin
blocks ostrich quenching, which leads to the increased emis-
sion intensity of ﬂuorescein.
In the present study, we showed that SLBs on porous
microspheres can stably encapsulate molecules for several
weeks. We also demonstrated the proof of concept for devel-
oping sensors and drug delivery systems based on the dis-
ruption of lipid membranes coating porous silica micro-
spheres loaded with ﬂuorescent or nonﬂuorescent com-
pounds. In this proof-of-concept study, we successfully used
several model compounds for lipid bilayer disruption: a non-
ionic detergent Triton X-100, a membrane active protein
-hemolysin, and a membrane lytic antimicrobial peptide
melittin.
II. MATERIALS AND METHODS
A. Materials
Egg phosphatidyl choline EPC, 1,2-dimyristoyl-sn-
glycero-3-phosphocholine DMPC, and 1,2-dimyristoyl-sn-
glycero-3-phospho-rac-1-glycerol sodium salt DMPG
were purchased from Avanti Polar Lipids Albaster, AL. Po-
rous silica microspheres 50 Å nominal pore size, 5 m
diameter were from Macherey-Nagel Easton, PA. Nonpo-
rous silica microspheres 5 and 20 m diameter were pur-
chased in dry form from Duke Scientiﬁc Palo Alto, CA.
Streptavidin-coated polystyrene microspheres with 20 m
diameter were purchased from Spherotech, Lake Forest, IL.
Fluorescein sodium salt, Triton X-100, and melittin were
purchased from Sigma. -hemolysin/-toxin was purchased
from Calbiochem San Diego, CA. NH4OH, H2O2, and HCl
were purchased from VWR West Chester, PA. De-ionized
ultrapure water Barnstead International, Dubuque, IA was
used throughout all experiments.
B. Preparation of ﬂuorescein- or biotin-loaded
microspheres
Silica microspheres were cleaned and treated with a mix-
ture of 4% NH4OH and 4% H2O2 at 80 °C for 10 min. The
microspheres were then rinsed in distilled water once and
treated with a mixture of 4% HCl and 4% H2O2 at 80 °C for
10 min. Microspheres were rinsed in distilled water ﬁve
times and suspended in distilled water. Portions of micro-
spheres 5 mg were suspended in microcentrifuge tubes con-
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taining 200 l of 10 mM ﬂuorescein or 25 mM biotin in tris
buffer 100 mM tris, 150 mM NaCl, pH 7.4 for a minimum
of three days.
C. Formation of supported lipid bilayers on
microspheres
Fluorescein- or biotin-loaded microspheres were sepa-
rated from ﬂuorescein or biotin solution by centrifugation
and coated with a single lipid bilayer as described
elsewhere.7,11,15 Brieﬂy, the lipid or mixture of lipids 1
mM in chloroform was dried under a stream of nitrogen
followed by vacuum for half an hour. Unilamellar vesicles15
were prepared by hydrating the dry lipids with tris buffer
followed by sonication Aquasonic, model 500, VWR for 20
min. Ice was added to the sonicator bath if necessary to
maintain ambient temperature. Lipid bilayers were formed
around the microspheres by a vigorous shaking of the micro-
spheres with a suspension of unilamellar vesicles using a
Vortex mixer for 5 min followed by a 25 min incubation
without shaking. Excess lipids and ﬂuorescein dye were re-
moved by rinsing the lipid-coated microspheres in tris buffer
at least 15 times. The microspheres were suspended in tris
buffer at a concentration of 5 mg/ml.
D. Scanning electron microscopy and confocal
scanning laser microscopy
The porous silica microspheres were characterized by
scanning electron microscopy SEM Hitachi S5200, 1 kV.
Lipid-coated ﬂuorescein-containing microspheres were im-
aged by using a confocal scanning laser microscope Zeiss
LSM510 equipped with an argon-ion laser.
E. Fluorimetry
Fluorescence measurements were performed by excitation
at 488 nm and collection of emission at 520 nm using a
Fluorolog-3 SPEX ﬂuorimeter Instruments S.A., Edison,
NJ.
F. Disruption of SLBs in suspension assays
A tube containing 200 μL of lipid-coated microspheres
that encapsulated ﬂuorescein was divided into two tubes. The
two aliquots were centrifuged and their supernatants were
mixed, in separate centrifuge tubes, with equal volumes of
either tris buffer or a membrane disrupting reagent. The ﬂuo-
rescence intensity of each mixture was immediately time
=0 recorded. Each mixture was mixed with its respective
microsphere sample in centrifuge tubes and incubated at
25 °C in the dark. After 30 min, the samples were centri-
fuged and the ﬂuorescence intensity of the supernatants was
measured. Microspheres were resuspended in their respective
supernatants. This process was repeated again and ﬂuores-
cence intensities were measured at 90 and 150 min. The
disrupting agents tested were 1 Triton X-100 at a ﬁnal con-
centration of 5% w/v, 2 -hemolysin, where three differ-
ent toxin concentrations: 15, 45, and 250 g /ml were used
at 37 and 25 °C with microspheres coated with EPC, or 3
melittin at a ﬁnal concentration of 220 M with micro-
spheres coated with either 100% EPC, 10:90 molar ratio
mixture of DMPG and EPC, or an 80:20 mixture of DMPG
and DMPC. All melittin experiments were conducted at
25 °C.
G. Detection of SLB disruption by -hemolysin
using ﬂow cytometry
Fluorescein is a pH-sensitive dye whose ﬂuorescence is
signiﬁcantly reduced below pH 7.0.37 We employed this
property by encapsulating ﬂuorescein by SLBs in an acidic
environment in the porous microspheres while suspending
the microspheres in a basic environment. The addition of
-hemolysin will create pores within the SLB, which allows
the movement of protons from the internal acidic environ-
ment of the microspheres to the external basic environment,
thus raising the pH within the pores where the ﬂuorescein is
stored and causing an increase in ﬂuorescence. For that rea-
son, 12106 porous microspheres were suspended in 1 mM
ﬂuorescein in the ﬂow cytometry sheath buffer, in which the
pH was adjusted to 2.6 in a total volume of 600 l, and
incubated overnight with shaking at room temperature. The
microspheres were sedimented by centrifugation and then
incubated with 1 mM EPC in 400 l sheath buffer pH 2.6
to form a SLB as described above. Excess lipids and ﬂuo-
rescein dye were removed by rinsing the lipid-coated micro-
spheres in sheath buffer four times, in which the pH was
adjusted to 11.0. The microspheres were then resuspended in
400 l of sheath buffer that has a pH of 11.0. An
-hemolysin stock solution of 200 g /ml was prepared in
sheath buffer pH 7.4 and kept on ice until used.
-hemolysin was added to the prepared microspheres at con-
centrations of 0, 5, 15, and 45 g /ml and was incubated
immediately at 37 °C with stirring. Fluorescence readings
were measured every 2 min while incubated at 37 °C by
using a FACScan ﬂow cytometer Becton-Dickinson, Sunny-
vale, CA with excitation at 488 nm. Fluorescence signals
were acquired on the FL-1 channel 525 nm by using log
ampliﬁcation and were analyzed with the CellQuest™ soft-
ware.
H. Preparation of microﬂuidic channels
Polydimethylsiloxane PDMS microchannels were con-
structed by using soft lithographic techniques adapted from
the literature.38 The microﬂuidic channels were fabricated
with weirs to hold the microspheres in place as described
elsewhere.11 The dimensions of the microchannel were 2 cm
in length, 250 m in width, and 60–70 m in height. In
order to trap the microspheres, the depth of the channel was
limited to 12–15 m near the outlet. The prepared PDMS
channel was irreversibly sealed onto a glass slide after ex-
posing both to an Ar plasma.38
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I. Release of ﬂuorescein upon disruption of SLBs
in a microchannel format
To create a packed microcolumn of lipid-coated micro-
spheres containing ﬂuorescein, 2 l of silica microsphere
diameter=20 m suspension 0.05 mg/l were injected
into a microﬂuidic channel by applying vacuum at the outlet
port of the microchannel, followed by the injection of 10 l
of ﬂuorescein-entrapped microsphere diameter=5 m sus-
pension 0.05 mg/l. The microsphere-packed microchan-
nel was mounted onto a vertical translational stage located in
the sample holder space of the ﬂuorimeter.11 Just below the
microsphere segment, the microchannel was irradiated with
an argon ion laser =488 nm excitation, 8–10 mW. The
inlet of the column was connected to a buffer reservoir, while
the outlet was connected to a vacuum source. As the ﬂuores-
cence intensity at 520 nm was monitored, several microliters
of tris buffer were passed through the microchannel before
the injection of Triton X-100. To avoid photobleaching, we
irradiated the microchannel right beneath the microsphere
segment, where the disruption of bilayers was detected by
monitoring the diffusion of ﬂuorescein from the porous mi-
crospheres into the buffer stream at the irradiated area. After
about half an hour, 10 l of 10% w /v Triton X-100 was
injected into the column through the inlet silicon tubing by
using a Hamilton syringe.
J. Detection of membrane interactions by downstream
biomolecular interactions of a compound released
upon SLB disruption
A microchannel was packed with a segment 1 mm of
streptavidin-coated microspheres 20 m diameter to
which a nonsaturating amount of ﬂuorescein biotin was
bound.39 This was followed by a segment 1 mm of blank
silica microspheres 20 m diameter and a segment
2 mm of lipid-coated porous microspheres containing
biotin. The blank silica microspheres served as the spacer to
prevent mixing of ﬂuorescein biotin microspheres with biotin
encapsulated microspheres. Biotin-loaded microspheres were
encapsulated with an 80:20 molar ratio mixture of DMPG
and DMPC. A 10 l aliquot of either 10% w /v Triton
X-100 or 220 M melittin was injected to the column. The
ﬂuorescein biotin microsphere segment was irradiated at 488
nm and the increase in its ﬂuorescence emission intensity
was measured at 520 nm every 10 min.
III. RESULTS AND DISCUSSIONS
A. Characterization of microspheres with SEM and
confocal microscopy
SEM of the porous microspheres used in this study Fig.
1a shows that they are spherical, with 90% of the mi-
crospheres having an average diameter of 5 m 10%
of the microspheres had a smaller diameter of 1–2 m.
Figures 1b and 1c show high resolution SEM images of
the surface of the microspheres. The manufacturer speciﬁes a
nominal pore diameter of 50 Å; however, from the SEM
image, it is clear that the pores are not regular in size and
also that the microspheres contain a fraction of pores that is
bigger than 50 Å. Silica microspheres are negatively
charged at a pH of 7.5.40 Fluorescein is also negatively
charged at this pH; nevertheless, incubating the porous mi-
crospheres in highly concentrated solutions for one day was
sufﬁcient to load the microspheres with detectable amounts
of ﬂuorescein. For our experiments, we incubated the micro-
spheres in ﬂuorescein for three days. After coating the
ﬂuorescein-loaded microspheres with lipid bilayers, the mi-
crospheres were rinsed with tris buffer 15 times. Rinsing the
microspheres even three times results in the formation of one
SLB rather than multilayers,8 but to remove excess ﬂuores-
cein, extra rinsing was needed. A confocal ﬂuorescence im-
age of the lipid-coated microspheres packed into a microcol-
umn Fig. 1d demonstrates that the dye is encapsulated
inside the microspheres.
B. Long term stability of a lipid bilayer supported on
porous microspheres
The stability of SLBs on ﬂuorescein encapsulated micro-
spheres was evaluated by monitoring the leakage of ﬂuores-
cein into solution Fig. 2. This was done by collecting the
supernatant after sedimenting the microspheres, as explained
under Sec. II. Monitoring was done for a period of one
month for microspheres that were stored at 25 and 4 °C.
Since the temperature can inﬂuence the ﬂuorescence
intensity,41 the ﬂuorescence of the supernatant was always
measured at room temperature. At the end of a one month
period, SLBs on microspheres were disrupted with 10%
w /v Triton X-100 in tris buffer and incubated for 30 min.
We assumed that this addition of Triton X-100 will com-
pletely disrupt the SLB and cause 100% leakage as we dem-
onstrated an 70-fold increase in ﬂuorescence intensity of
the supernatant upon disruption of the SLBs with Triton








FIG. 1. Images of porous microspheres. a SEM image of porous silica
microspheres average diameter=5 m. b High resolution SEM image of
a porous silica microsphere surface. c Higher resolution image of a porous
silica microsphere showing its porous surface. d Confocal ﬂuorescence
image of microspheres containing ﬂuorescein encapsulated in lipid bilayer
membranes packed in a microcolumn.
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porous microspheres and 1 M ﬂuorescein solutions kept at
25 and 4 °C. All the intensities were normalized to the in-
tensity at day 1 and corrected for any possible ﬂuctuations in
efﬁciency of ﬂuorescence excitation or emission detection
during the experimental period by using ﬂuorescein solutions
1 M, 4 and 25 °C as controls according to the following:
I =  Ii − I0I0  −  Iflc − Iflc,0Iflc,0  , 1
where I is the normalized and corrected intensity of the su-
pernatant for each day, Ii is the ﬂuorescence intensity mea-
sured for the supernatant each day, I0 is the ﬂuorescence
intensity of the supernatant on day 1, Iflc and Iflc,0 are the
intensities of the control ﬂuorescein solutions on each day
and on day 1, respectively. The observed ﬂuctuation in inten-
sity of the controls was negligible. The leakage of the dye
during the one month period is illustrated in Fig. 2, as rep-
resented by the traces with open symbols. The total ﬂuores-
cence intensity increase at the end of the one month period
was 7.2-fold at 25 °C and 2.5-fold at 4 °C relative to
their corresponding initial readings.
The percent leakage of the dye into solution, relative to
that caused by adding Triton X-100, was calculated accord-
ing to the following:
% Leakage =  Ii − I0ITrt − I0100, 2
where ITrt is the total release of the dye due to the disruption
by Triton X-100. The traces with closed symbols in Fig. 2
represent the percentage of leakage of the dye. The percent-
age of leakage of ﬂuorescein into solution after 30 days for
lipid-coated microspheres kept at 25 °C was 6.9%, while
that of microspheres kept at 4 °C was 2.4%. It is known
that lipid bilayer membranes are more stable at lower
temperatures.42 The greater amount of ﬂuorescein leakage
through the SLB observed at 25 °C may be due to the in-
creased lateral diffusion of lipid molecules as well as the
increased rate of diffusion of ﬂuorescein. At both tempera-
tures, the leakage is very low, and for the purpose of the
types of assays described here, this leakage is considered
negligible. In this study, we formed the SLB by using EPC,
which is a mixture of saturated and unsaturated lipids with
different molecular sizes and phase transition temperatures.43
The phase transition temperature of EPC is below 0 °C, and
at both 25 and 4 °C, the membrane is in a ﬂuid phase. The
leakage might be further minimized by using a suitable lipid
composition that has a phase transition temperature higher
than that of EPC.42
Our data suggest that the lipid membranes on micro-
spheres are relatively stable for at least one month. In com-
parison, lipid vesicles cannot be stored for more than one
week without a substantial loss of encapsulated compounds,
and the preparation of fresh vesicle samples is often required
for long term studies. Thus, the use of robust supported lipid
bilayers on porous silica microspheres can have advantages
over the use of lipid vesicles in applications requiring main-
tenance of encapsulation properties over a long period of
time as they are easier to handle and are more uniform in size
than lipid vesicles.
C. Detecting SLB disruption in suspension assays
Previous suspension studies on disruption of lipid bilayers
were performed by using small unilamellar vesicles.26,44 In
those experiments, the disruption of the lipid bilayer mem-
branes was detected by monitoring the unquenching of a
highly concentrated encapsulated dye.26 In the present work,
disruption is monitored via release of ﬂuorescein dye from
porous microspheres, by measuring the increase in ﬂuores-
cence intensity of the supernatant at 520 nm. As depicted in
Fig. 3a, microspheres were ﬁrst suspended in tris buffer
containing the disruptor. Microspheres can be easily sedi-
mented by centrifugation; thus, a portion of the supernatant
can be taken for measurement. The measured portion was
added back to the microsphere sample for semicontinuous
monitoring. The scattering effect that is present in vesicle
based studies can be minimized by measuring the ﬂuores-
cence of a microsphere-free supernatant.45,46
1. Detecting the disruption of SLBs by Triton X-100
in suspension assays
Triton X-100 can disrupt lipid membranes within
milliseconds.20 As depicted in the schematic in Fig. 3b, the
encapsulated dye will be released when the SLB is solubi-
lized by Triton X-100. An evaluation of the dye release upon
disrupting the SLB by adding Triton X-100 was carried out
by plotting the ﬂuorescence intensity of the released dye in
the supernatant, normalized to the initial ﬂuorescence inten-
sity reading, versus time Fig. 4. The disruption of SLBs
encapsulating ﬂuorescein in microspheres by Triton X-100
caused an increase of more than 70-fold in ﬂuorescence in-
tensity of the supernatant when examined after 30 min of










































FIG. 2. Stability of lipid bilayers on porous microspheres. Normalized and
corrected intensity of supernatant ﬂuorescence intensity open symbols, y
axis to the right and percent leakage closed symbols, y axis to the left are
plotted against time. See text for details on calculating the normalized and
corrected intensity and percent leakage. This ﬁgure is representative of three
replicates.
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incubation. There was no signiﬁcant change in the ﬂuores-
cence intensity of the supernatant after 30 min, suggesting
relatively rapid equilibration of the release of ﬂuorescein.
The leakage in the absence of Triton X-100 is shown in the
trace with ﬁlled rectangles in Fig. 4. The trace with ﬁlled
circles represents a control sample of lipid-coated porous mi-
crospheres without ﬂuorescein. These results suggest that
Triton X-100 is an efﬁcient disruptor of lipid membranes
supported on porous silica microspheres and that the release
of the dye can be viewed as an effective measure of mem-
brane disruption.
2. Detecting the interaction of -hemolysin
with SLBs in suspension assays
We examined the interaction of membrane active biomol-
ecules, such as -hemolysin and melittin, with the SLBs in
suspension assays. -hemolysin is a membrane active pro-
tein that is secreted by Staphylococcus aureus and has a
molecular weight of 33 kDa. -hemolysin is also referred
to as -toxin, although the latter is the precursor of
-hemolysin with a propeptide sequence of 26 amino acids,
and its molecular weight is 36 kDa.47 -hemolysin forms
heptameric pores 1–2 nm in diameter in phospholipid
bilayers.22 The poration of membranes by -hemolysin does
not depend on the charge of the lipids, and the toxin is most
reactive at 37 °C.22,48 Suspension assays were performed as
described above for Triton X-100 at 25 and 37 °C for three
different toxin concentrations: 15, 45, and 250 g /ml. The
release of ﬂuorescein dye upon exposure of the microspheres
to -hemolysin was monitored over time and is presented in
Fig. 5. The increase in ﬂuorescence intensity at 150 min in
comparison to 0 min was 6.5-fold at 37 °C and 3-fold at
25 °C for all three concentrations data for 45 g /ml of
toxin are not shown in the ﬁgure for clarity. The release of
similar quantities of the dye for all three concentrations in-
dicated the presence of an adequate amount of -hemolysin
in the medium. The data conﬁrmed the enhanced activity of
the toxin at 37 °C in comparison to 25 °C. The addition of
Triton X-100 after 150 min caused a total disruption of bi-
layers, resulting in an increased ﬂuorescence intensity of 50-





FIG. 3. Suspension assay. a Schematic representation of suspension study.
Initially, the microspheres are suspended with the disruptor. Solution will be
separated from microspheres by centrifugation and analyzed for ﬂuorescein
released by the microspheres. b Schematic representation of total disrup-
tion of SLBs on porous silica microspheres with ﬂuorescein dye inside.
Triton X-100 will solubilize the entire bilayer while membrane active pep-
tides and proteins will form channels or pores through the membrane.





















FIG. 4. Detecting disruption of SLBs by Triton X-100 in a suspension assay.
The normalized ﬂuorescence intensity at 520 nm of supernatants was plotted
against time for suspension assays of EPC bilayer disruption by Triton
X-100 triangles. The ﬂuorescence intensity is normalized to the original
intensity. Squares represent the control with ﬂuorescein encapsulated micro-
spheres with no Triton X-100 added. Circles represent the control with
empty porous microspheres coated with lipid bilayer, and Triton X-100 is
added. This ﬁgure is representative of three replicates.





















250 g/mL, 37 oC
15 g/mL, 37 oC
0 g/mL, 37 oC
250 g/mL, 25 oC
15 g/mL, 25 oC
0 g/mL, 25 oC
Triton X-100
FIG. 5. Detecting the disruption of SLBs by -hemolysin in a suspension
assay. Normalized ﬂuorescence intensity at 520 nm vs time for suspension
assays of EPC-coated, ﬂuorescein-ﬁlled porous microspheres with different
concentrations of -hemolysin added. 10% w /v Triton X-100 was added
after 150 min. This ﬁgure is representative of three replicates.
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the porous microspheres after the exposure of the SLBs to
-hemolysin.
The interaction of -hemolysin with the SLB in compari-
son to Triton X-100 resulted in a smaller amount and rate of
dye release. This is not unexpected, considering the toxin’s
mechanism of membrane interaction, as the release is af-
fected by the size and the amount of pores formed by the
toxin on the lipid membranes. This observation is consistent
with reports that -hemolysin will not sufﬁciently disrupt the
lipid bilayers of vesicles to release all the encapsulated dye;
for example, only 27% of the dye encapsulated in EPC
vesicles was released upon incubation with -hemolysin.26
We investigated several different lipid formulations, which
contain different quantities of cholesterol and phosphatidyl
ethanolamine along with EPC, in an effort to enhance the
disruption by -hemolysin data not presented; none of the
lipid mixtures enhanced the degree of dye leakage beyond
that observed with EPC alone. The toxin concentrations we
used in this study to cause a detectable interaction were
higher than those used in many published works,49–51 which
may be due to the stability of the bilayers of the chosen
lipids on solid supports in comparison to lipid vesicles or the
assay format.
3. Detecting the interaction of -hemolysin
with SLBs using ﬂow cytometry
To evaluate whether using a different assay format would
allow us to detect the activity of lower -hemolysin concen-
trations, we performed a ﬂow cytometry assay, in which the
detection was based on encapsulating a pH-sensitive dye.
Fluorescein is a pH-sensitive dye, whose ﬂuorescence is sig-
niﬁcantly reduced below a pH of 7.0.37 This property was
employed in our sensing system, in which ﬂuorescein was
encapsulated by SLBs in an acidic environment in the porous
microspheres while suspending the microspheres in a basic
environment. We expect that the addition of -hemolysin
will create pores within the SLB, which will allow the move-
ment of protons from the internal acidic environment of the
microspheres to the external basic environment, thus raising
the pH within the pores where the ﬂuorescein is stored and
causing an increase in ﬂuorescence. Flow cytometry is a very
sensitive method that allows the simultaneous measurement
of multiple ﬂuorescence signals as a result of the illumina-
tion of single cells or microscopic particles in suspension as
they ﬂow rapidly through a laser beam. Microspheres have
been used in a variety of ﬂow cytometric assays for biosens-
ing and detecting molecular interactions.7,52–54 We used ﬂow
cytometry to detect interactions of -hemolysin with the
SLB at 37 °C; in this case, directly measuring the ﬂuores-
cence of the microspheres, rather than examining the ﬂuo-
rescence of the supernatant as we did in the suspension as-
says.
We determined the ﬂuorescence every 2 min and normal-
ized the reading to the ﬂuorescence reading before adding
-hemolysin 0 min reading. Figure 6 shows that without
adding -hemolysin, there was a slight increase in ﬂuores-
cence over time. This may be due to the leakage of protons
from the SLB-encapsulated microspheres. However, upon
addition of -hemolysin, at concentrations of 5 and
15 g /ml, there was an increased ﬂuorescence caused by
permeation of the SLBs. This increase in ﬂuorescence for
both concentrations was initially slow at the beginning, then
increased after 10 min and reached a plateau at around 24
min. The -hemolysin concentration of 45 g /ml caused
only a slight increase in ﬂuorescence. We also tested other
concentrations of -hemolysin, including 2.5, 10, 25, and
30 g /ml. All these concentrations gave a curve similar to
that of 5 g /ml -hemolysin data not shown. Further-
more, upon monitoring all the seven concentrations of the
-hemolysin tested for a longer time, the ﬂuorescence gradu-
ally declined to 1 after 76 min. Our ﬁndings indicated that
-hemolysin permeated the SLB and allowed proton move-
ment, which was detectable by the increase in the ﬂuores-
cence of the pH-sensitive dye ﬂuorescein. However, with
time, a plateau was reached, which was followed by a de-
cline in ﬂuorescence that may be caused by two factors: one
is the equilibration of protons and hydroxyl ions across the
SLB, and the second is the possible leakage of ﬂuorescein
from the particles after excessive pore formation by
-hemolysin. The higher concentration of -hemolysin
45 g /ml seems to have caused excessive poration of the
SLB. This may either allow a faster equilibration of protons
and hydroxyl ions across the SLB or, alternatively, cause a
faster leakage of ﬂuorescein, and thus, no signiﬁcant change
in ﬂuorescence was detected. This assay format enabled us to
detect the action of -hemolysin at concentration as low as
2.5 g /ml, although the optimal response was obtained at a
concentration of 15 g /ml.
4. Detecting the interaction of melittin with SLBs in
suspension assays
We also examined the disruption of SLBs in suspension
assay by using the membrane active peptide, melittin. Melit-





















FIG. 6. Detecting the disruption of SLBs by -hemolysin by ﬂow cytometry.
Normalized ﬂuorescence intensity at 525 nm vs time for suspension assays
of porous microspheres ﬁlled with pH-sensitive ﬂuorescein and those coated
with EPC with different concentrations of -hemolysin added and incubated
at 37 °C. The pH outside the microspheres was 11.0, whereas inside it was
2.6. This ﬁgure is representative of three replicates.
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tin, the principal toxic component in bee venom, is an anti-
microbial peptide with 26 amino acid residues that has a
strong interaction with negatively charged lipids. Melittin
tends to form pores in lipid membranes with zwitterionic
lipids; however, it can disrupt membranes of negatively
charged lipids in a “detergentlike” action,55–57 although a
higher concentration of melittin is required for the latter
effect.57 On the other hand, when anionic lipids are added to
zwitterionic lipids in vesicles, this confers resistance to
melittin action.58,59
We examined the interaction of melittin with SLBs con-
sisting of one of the following: 100% EPC, a 90:10 mixture
molar ratio of EPC and DMPG a mixture of a zwitterionic
lipid with a negatively charged lipid, or 80:20 mixture mo-
lar ratio of DMPG and DMPC a mixture of a negatively
charged lipid with a length-matched zwitterionic lipid. To
evaluate the interaction with these different SLB composi-
tions, we performed suspension assays by exposing to aque-
ous solutions of melittin at room temperature. We found that
the results for the three lipid mixtures tested were compa-
rable; hence, we are presenting here only the results for the
80:20 molar ratio mixture of DMPG and DMPC Fig. 7.
The addition of melittin led to a gradual release of the en-
capsulated ﬂuorescein Fig. 7. The release of ﬂuorescein
from porous microspheres coated with the different lipid
mixtures was noticed as early as 10 min after incubating with
melittin. In the absence of melittin, the leakage was low Fig.
7, which is important as these microspheres can be used in
studies for a longer period of time without losing their sen-
sitivity.
From these observations, we conclude that melittin,
whether in the presence or in the absence of DMPG in bi-
layers, resulted in the release of an encapsulated dye from
porous microspheres through enhanced toxin-membrane in-
teractions. We could not evaluate if melittin would interact in
a detergentlike fashion with a SLB composed of only anionic
phospholipids because these lipids are negatively charged,
and so are our microspheres, which may cause instability of
the SLBs.
Although the release of ﬂuorescein caused by melittin is
not high as in the case of Triton X-100, it is notable in
comparison to the release observed with -hemolysin. This
experiment demonstrates the possibility of forming bilayers
composed mainly of negatively charged lipids on negatively
charged porous silica microspheres. The ability to form lipid
bilayers, consisting of mixtures of negative and zwitterionic
lipids on silica surfaces, was reported previously60,61 and it is
thought that negative lipids will partially segregate to the
outer leaﬂet of such membranes.61 Although we used a
higher molar fraction of DMPG than that of DMPC, there is
a possibility that the membranes formed had DMPG-rich
outer leaﬂets. Detailed spectroscopic studies will be neces-
sary to characterize the likely complex structure of such
lipid bilayers on porous silica microspheres. The melittin
experiments suggest the possibility of developing silica
microsphere-based membrane-toxin interaction studies for
other membrane active cationic peptides.
Although the reports in literature showed that the disrup-
tion of lipid membranes either by membrane active peptides
or proteins can release a large amount of encapsulated com-
pounds from unilamellar vesicles,22,27,32 we did not observe
this with lipid-coated porous silica microspheres. One can
argue the possibility of having multilayers of lipid bilayers
around the microspheres; however, we previously demon-
strated that this is not the case.8 On the other hand, although
the effect of the silica support on the lytic activity of mem-
brane active compounds is not well understood, some studies
suggest that, by increasing the interfacial distance between
lipid bilayers and the support, the disruption can be
enhanced.24,62
D. Detecting SLB disruption in microﬂuidic format
Having analyzed the detergent’s and toxins’ capabilities of
interacting with membranes supported on microspheres in
suspension, we next explored the possibilities of developing
microﬂuidic chemical and biochemical sensors to detect
membrane-detergent and membrane-toxin interactions. These
microﬂuidic studies were based on the detection of the re-
lease of a ﬂuorescent dye or a nonﬂuorescent compound
from porous microspheres packed into a microcolumn inside
a microﬂuidic channel. First, we wanted to demonstrate that
we could pack lipid-coated porous microspheres in a micro-
column without causing membrane disruption during the
packing process. Figure 8a shows the optical micrograph of
a SLB-microsphere packed microcolumn. The packed seg-
ment was 2 mm long. The monitoring of the released ﬂuo-
rescein from the microspheres was performed at a point just




















FIG. 7. Detecting the disruption of SLBs consisting of A EPC or EPC/
DMPG or B DMPG/DMPC by using melittin in a suspension assay. Nor-
malized ﬂuorescence intensity at 520 nm vs time for suspension studies
with 220 M melittin. Microspheres were coated either with EPC, 10:90
molar ratio mixture of DMPG and EPC, or 80:20 molar ratio mixture of
DMPG and DMPC. 10% w /v Triton was added after 90 min. The open
symbols represent the controls in the absence of melittin. This ﬁgure is
representative of three replicates.
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below the microsphere segment, as indicated in Fig. 8b.
Since we monitor a region that is originally nonﬂuorescent,
the alignment of the microcolumn with the excitation source
and the detector is challenging. To overcome this, we ﬁrst
aligned the ﬂuorescent microsphere segment with the beam
from an argon ion laser and the detector, then vertically
moved the column to a suitable region while monitoring the
ﬂuorescent signal from the microcolumn, as shown in Fig.
9a. The detection region should be downstream from the
microsphere segment, where the signal does not interfere
with the one that arises from adjacent ﬂuorescent micro-
spheres. The microcolumn was irradiated at 488 nm and
ﬂuorescence intensity was monitored at 520 nm.
1. Stability of SLBs on microspheres packed into
a microchannel
The packing process of the microspheres in a microcol-
umn or the close contacts of the packed microspheres can
cause disruption or instability of the SLBs on these micro-
spheres. We evaluated the latter possibility by examining the
stability of SLBs on porous microspheres, containing ﬂuo-
rescein dye, by monitoring the leakage of the dye from mi-
crospheres. Figure 9b shows the ﬂuorescence intensity of
the detection region, at ﬂow and no ﬂow conditions. A tris
buffer was ﬂowed through the column 1.2 l /min for
15 min and then stopped for another 15 min. Had the dye
FIG. 8. Microcolumn conﬁgurations for membrane interaction analyses. a
Optical micrograph of a microsphere packed microcolumn. Microspheres
are retained by having a weirlike structure at the bottom of the microcol-
umn. b Schematic of the microcolumn showing the detection point for the
phospholipid bilayer disruption study with Triton X-100. The detection
point marked with X is irradiated with a 488 nm Ar-ion laser beam. c
Schematic of the microﬂuidic biosensor based on bilayer disruption. A mi-
crocolumn is packed with a 1 mm long ﬂuorescein-biotin-coated streptavi-
din microsphere segment at the bottom with a stacked 1 mm long spacer
microsphere segment and, ﬁnally, a 2 mm long biotin encapsulated micro-
sphere segment.


























































FIG. 9. Stability and Triton X-100 disruption of SLBs in microﬂuidic stud-
ies. a Alignment of the microsphere packed microcolumn for ﬂuorimetry
experiments. b Microﬂuidic stability study. The very low intensity indi-
cates the stability of lipid-coated microspheres when packed in the micro-
column. c Microﬂuidic disruption upon introduction of 10% w /v Triton
X-100. This ﬁgure is representative of three replicates.
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leaked out to a signiﬁcant extent, it would have been trans-
ported into the buffer stream and increased the ﬂuorescence
intensity at the detection region. However, no signiﬁcant
leakage of the encapsulated dye occurred from the lipid
membrane-coated porous microspheres, which indicated that
the SLBs were stable enough to withstand packing into a
microcolumn. Thus, we were conﬁdent that packing lipid-
coated porous microspheres into microcolumns does not dis-
rupt the SLBs to a signiﬁcant extent.
2. Detection of membrane interaction by release
of a ﬂuorescent dye
We evaluated this microﬂuidic sensor in detecting the re-
lease of encapsulated ﬂuorescein upon disruption of the
SLBs by using Triton X-100. After injecting 10 l of 10%
w /v Triton X-100 into the ﬂuorescein encapsulated micro-
sphere containing microcolumn, microspheres were incu-
bated with Triton X-100 at no ﬂow condition for about 5
min. The ﬂow was then started to move the released ﬂuores-
cein dye to the detection point. As Fig. 9c shows, a 25-fold
increase in ﬂuorescence intensity was observed. The follow-
ing decrease in ﬂuorescence intensity was due to the dilution
of the released dye in the transport buffer. Following that and
in the absence of ﬂow, the intensity was nearly constant. This
suggested that the dye was relatively immobile in the ab-
sence of buffer ﬂow. The increase in ﬂuorescence intensity
due to Triton X-100 disruption of the SLBs obtained here
was less than that observed in the suspension studies. This
was mainly due to the fact that we were monitoring the con-
tinuous release of dye in the microcolumn, whereas in sus-
pension studies, we monitored the total dye that was accu-
mulated for a certain period of time. The initial high
ﬂuorescence intensity can be due to the release of ﬂuorescein
that was entrapped near the surface of the porous silica mi-
crosphere and inner leaﬂet of the lipid bilayer. After a certain
period of time, the ﬂuorescence intensity became less due to
the slow diffusion of dye from microsphere pores and the
nearly complete removal of the dye from porous micro-
spheres.
3. Detection of interactions with SLBs on porous
microspheres through the release of a
bioactive compound
We aimed at demonstrating that our microﬂuidic system
can be utilized to detect the release of nonﬂuorescent com-
pounds upon disruption of SLBs on microspheres in packed
microcolumns. Nonﬂuorescent compounds of interest might
include highly bioactive compounds such as cofactors, cata-
lysts, and ligands that can engender a signiﬁcant downstream
ampliﬁcation mechanism. As a model, we chose biotin as a
ligand with high biospeciﬁc activity. This was done in a mi-
crochannel that was designed to have two active segments of
microspheres separated by a passive one blank micro-
spheres. In the ﬁrst segment, the disruption of SLBs on
microspheres took place, resulting in the release of the non-
ﬂuorescent compound, biotin. In the second segment, subse-
quent interactions of the released biotin occurred, which
enabled its detection through the ostrich quenching-
unquenching phenomena in ﬂuorescein biotin-streptavidin
interaction.39 When a nonsaturating amount of ﬂuorescein-
conjugated biotin is bound to streptavidin, ﬂuorescein inter-
acts with cis biotin-binding pocket on streptavidin. This re-
sults in a quenching of its ﬂuorescence intensity, which is
known as ostrich quenching. The introduction of free biotin
to this system displaces the ﬂuorescein from the cis binding
pocket, thus unquenching the ﬂuorescence signal.39
In our study, as shown in Fig. 8c, a segment of strepta-
vidin microspheres diameter=20 m coated with biotin
that is conjugated to ﬂuorescein is packed at the bottom of
the microﬂuidic channel. Packed on top of that is a segment
of blank silica nonporous microspheres followed by a seg-
ment of lipid-coated porous silica microspheres that encap-
sulate biotin. Our aim was to disrupt the SLB by Triton
X-100 or melittin so as to release biotin, which, upon reach-
ing the second segment, binds to streptavidin and displaces



































FIG. 10. Microﬂuidic membrane interaction analyses by release of com-
pounds: a with 10% w /v Triton X-100 and b with 220 M melittin.
The ﬂow rate is 1.2 l/min. This ﬁgure is representative of three replicates.
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ﬂuorescein from the biotin-binding pocket on streptavidin,
leading to unquenching, which is detectable as an increase in
ﬂuorescence intensity at that segment.
Figure 10a illustrates the detection of disruption of lipid
membranes with Triton X-100. The initial decrease in ﬂuo-
rescence intensity was due to photobleaching, resulting from
the exposure of the ﬂuorescein-biotin segment to the Ar-ion
laser.11 To minimize the photobleaching, the microsphere
segment was scanned only for 30 s at 10 min intervals. At 18
min, 10 l of Triton X-100 10% w /v were injected. The
ﬂow rate was 1.2 l /min and the dead volume from the
injection point to the detection point was about 10 l. As
seen previously Fig. 9c, initially, the porous microspheres
released a large amount of entrapped biotin from porous mi-
crospheres, causing unquenching of biotin-conjugated ﬂuo-
rescein, which corresponds to the high ﬂuorescence intensity
observed at 30 min Fig. 10a. The presence of excess bi-
otin can cause the dissociation of ﬂuorescein-biotin from
streptavidin; thus, the decrease in ﬂuorescence intensity after
30 min may be due to the combined effects from pho-
tobleaching and the dissociation of some ﬂuorescein-biotin
from streptavidin. Figure 10b shows the data for the release
of biotin as a result of melittin interaction with SLBs. 20 l
of melittin 220 M was injected into the microsphere
packed microchannel at 18 min. The ﬂow rate was main-
tained at 1.2 l /min. The initial ﬂuorescence intensity de-
crease is again due to photobleaching. The reading at 40 min
indicated an increase in ﬂuorescence intensity as opposed to
the expected decrease due to photobleaching, indicating un-
quenching of ﬂuorescein. At this point, the frequency of laser
scanning of the column was decreased from 10 to 30 min to
prevent excess photobleaching. This was particularly a con-
cern with melittin because we observed in the suspension
studies that its disruption of bilayers caused a slow release;
hence, photobleaching can have a signiﬁcant effect on the
detection of ﬂuorescence intensity. At 60 min, we detected an
increase in ﬂuorescence due to the unquenching of ﬂuores-
cein. The increase in ﬂuorescence intensity caused by melit-
tin was not as high as that observed with Triton X-100,
which is in accordance with our suspension studies.
IV. CONCLUSIONS
In this work, we demonstrated the feasibility of using
lipid-coated porous silica microspheres that encapsulate
compounds as a platform for developing new chemical sen-
sors for membrane-detergent and membrane-toxin interac-
tions. We successfully encapsulated compounds into porous
silica microspheres by forming a supported phospholipid bi-
layer that was stable for up to a month. We established that
the SLBs on porous microspheres can endure experimental
conditions necessary for their incorporation into packed mi-
crocolumns while maintaining the bilayer integrity and func-
tionality.
We have demonstrated membrane interaction studies with
SLBs on porous silica microspheres in suspensions and in
microcolumns. We showed that the membrane interactions
with detergents and membrane active proteins and peptides
in microcolumns can be detected by i the release of a ﬂuo-
rescent dye and ii the release of compounds with high bio-
activity by using biotin as a model. For proof-of-principal
studies, we used Triton X-100, -hemolysin, and melittin as
membrane disruptors. We have further demonstrated the for-
mation of stable SLBs containing negatively charged lipids
on porous silica microspheres.
Further studies are needed to analyze the encapsulation
efﬁciency of microspheres with different pore sizes and with
different lipid formulations. The prototype microﬂuidic as-
says demonstrated here can be further reﬁned by optimizing
ﬂuidic and detection systems. In principle, the methods de-
scribed here can be used to study and detect the action of a
wide variety of membrane active compounds. The micro-
spheres with SLBs can be useful for a variety of high
throughput screening methods.
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